Literature DB >> 10870487

The management of cancer pain.

N I Cherny1.   

Abstract

Any therapeutic strategy developed for patients experiencing cancer pain depends on the goals of care, which can be broadly categorized as prolonging survival, optimizing comfort, and optimizing function. The relative priority of these goals for any individual should direct therapeutic decision-making. By combining primary treatments, systemic analgesic agents, and other techniques, most cancer patients can achieve satisfactory relief of pain. In cases where pain appears refractory to these interventions, invasive anesthetic or neurosurgical maneuvers may be necessary, and sedation may be offered to those with unrelieved pain at the end of life. The principles of analgesic therapy are presented, as well as the practical issues involved in drug administration, ranging from calculating dosage to adverse effects, and, when necessary, how to switch and/or combine therapies. Adjuvant analgesics, which are drugs indicated for purposes other than relief of pain but which may have analgesic effects, are also listed and discussed in some detail. Surgical and neurodestructive techniques, such as rhizotomy or cordotomy, although not frequently required or performed, represent yet other options for patients with unremitting pain and diminished hope of relief. Although cancer pain can be a complex medical problem arising from multiple sources, patients should be assured that suffering is not inevitable and that relief is attainable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10870487     DOI: 10.3322/canjclin.50.2.70

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  17 in total

Review 1.  Palliative surgery for cancer pain.

Authors:  Laurence McCahill; Betty Ferrell
Journal:  West J Med       Date:  2002-03

Review 2.  Sedation for comfort at end of life.

Authors:  Olivia Walton; Sharon M Weinstein
Journal:  Curr Pain Headache Rep       Date:  2002-06

Review 3.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

4.  Assessing and treating pain in hospices: current state of evidence-based practices.

Authors:  Keela Herr; Marita Titler; Perry Fine; Sara Sanders; Joe Cavanaugh; John Swegle; Chris Forcucci; Xiongwen Tang
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

5.  Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center.

Authors:  Tisha M Felder; Lincy S Lal; Charles L Bennett; Frank Hung; Luisa Franzini
Journal:  Community Oncol       Date:  2012-02-10

6.  Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.

Authors:  Diana J Wilkie; Robert Molokie; Debra Boyd-Seal; Marie L Suarez; Young Ok Kim; Shiping Zong; Harriet Wittert; Zhongsheng Zhao; Yogen Saunthararajah; Zaijie J Wang
Journal:  J Natl Med Assoc       Date:  2010-01       Impact factor: 1.798

7.  Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain.

Authors:  Hongming Pan; Zaiyun Zhang; Yiping Zhang; Nong Xu; Liqin Lu; Chunfeng Dou; Yong Guo; Shixiu Wu; Jianhua Yue; Dongping Wu; Yuechu Dai
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

8.  Symptom masquerade: understanding the meaning of symptoms.

Authors:  Marlene Z Cohen; Lori Williams; Patti Knight; Julie Snider; Kavin Hanzik; Michael J Fisch
Journal:  Support Care Cancer       Date:  2004-01-20       Impact factor: 3.603

9.  The prognostic and predictive role of pain before systemic chemotherapy in recurrent ovarian cancer: an individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) of 1226 patients.

Authors:  H Woopen; R Richter; G Inci; S Alavi; R Chekerov; J Sehouli
Journal:  Support Care Cancer       Date:  2019-08-05       Impact factor: 3.603

10.  Strontium 89 in the treatment of pain due to diffuse osseous metastases: a university hospital experience.

Authors:  Ebrahim Ashayeri; Adedamola Omogbehin; Rajagopalan Sridhar; Ravi A Shankar
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.